
Tetra Bio-Pharma (OTC: TBPMF) Provides an Update on its U.S. REBORN1 Clinical Trial
First clinical study to assess cannabis as an alternative to morphine Tetra completes manufacturing of QIXLEEF clinical trial drug for REBORN1 trial Export permit received from Health Canada for immediate shipping to USA OTTAWA, ON […]